Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response

Journal of Trauma - Injury, Infection and Critical Care

Volumn 58, Issue 5, 2005, Pages 925-932

  Utter, Garth H ^a   Owings, John T ^a   Lee, Tzong Hae ^c   Paglieroni, Teresa G ^e   Reed, William F ^c,d   Gosselin, Robert C ^b   Holland, Paul V ^b   Busch, Michael P ^c,d   Dunn, Julie A ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BloodSource   (United States)

^f NONE

Author keywords

Blood transfusion; Compensatory anti inflammatory response syndrome; Immunosuppression; Lymphocytes; Microchimerism; Trauma

Indexed keywords

HLA DR ANTIGEN; MITOMYCIN C; PHYTOHEMAGGLUTININ;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MICROCHIMERISM; MIXED LEUKOCYTE CULTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME;

ADULT; BLOOD DONORS; BLOOD TRANSFUSION; CHIMERISM; FEMALE; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; PROSPECTIVE STUDIES; WOUNDS AND INJURIES;

EID: 20144367508     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000162142.72817.5C     Document Type: Article

References (25)

1. Rawal BD, Davis RE, Busch MP, Vyas GN. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection. Transfus Med Rev. 1990;4:36-41.
2. Busch MP, Lee TH, Heitman J. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood. 1992;80:2128-2135.
3. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther. 2002;9:389-395.
4. Slichter SJ. Platelet refractoriness and alloimmunization. Leukemia. 1998;12:S51-S53.
5. Claas FH, Smeenk RJ, Schmidt R, van Steenbrugge GJ, Eernisse JG. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol. 1981;9:84-89.
6. Schroeder ML. Transfusion-associated graft-versus-host disease. Br J Haematol. 2002;117:275-287.
7. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg. 1996;20:454-459.
8. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg. 2001;193:237-244.
9. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003;54:908-914.
10. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997; 132:620-625.
11. Malone DL, Dunne J, Tracy JK, et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma. 2003;54:898-907.
12. Lee TH, Paglieroni T, Ohio H, Holland PV, Busch MP. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood. 1999;93:3127-3139.
13. Kruskall MS, Lee TH, Assmann SF, et al. Survival of transfused donor white blood cells in HIV-infected recipients. Blood. 2001; 98:272-279.
14. Reed W, Lee TH, Vichinsky EP, Lubin BH, Busch MP. Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction. Transfusion. 1998; 38:1041-1045.
15. Adams PT, Davenport RD, Reardon DA, Roth MS. Detection of circulating donor white blood cells in patients receiving multiple transfusions. Blood. 1992;80:551-555.
16. Utter GH, Owings JT, Lee TH, et al. Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. J Trauma. 2004;57:702-708.
17. Lee TH, Paglieroni TG, Utter GH, et al. High-level long-term leukocyte microchimerism following transfusion of leukoreduced blood components to patients resuscitated following severe traumatic injury. Transfusion. (In press).
18. Faist E, Schinkel C, Zimmer S, et al. Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signaling. J Trauma. 1993;34:846-854.
19. Horgan AF, Mendez MV, O'Riordain DS et al. Altered gene transcription after burn injury results in depressed T-lymphocyte activation. Ann Surg. 1994;220:342-352.
20. O'Sullivan ST, Lederer JA, Horgan AF, et al. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg. 1995;222:482-492.
21. Faist E, Mewes A, Baker CC, et al. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma. 1987;27:837-848.
22. Miller-Graziano CL, Szabo G, Griffey K, et al. Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression. J Clin Immunol. 1991;11:95-1102.
23. Kelly JL, O'Suilleabhain CB, Soberg CC, Mannick JA, Lederer JA. Severe injury triggers antigen-specific T-helper cell dysfunction. Shock. 1999;12:39-45.
24. Moore FA, Sauaia A, Moore EE, et al. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma. 1996;40:501-512.
25. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 2001;16:83-96.